Delphx Announces Non-Brokered Private Placement
MWN-AI** Summary
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a pioneering firm in structured products, has announced its intention to initiate a non-brokered private placement of up to 5,000,000 units at a price of C$0.05 per unit. This move aims to raise up to C$250,000 in gross proceeds. Each unit will comprise one common share and a warrant that permits the purchase of an additional common share at C$0.08 for a period of two years following issuance. The offering is contingent upon approval from the TSX Venture Exchange, and the issued securities will be subject to a four-month hold period post-issuance.
The company may also implement finder’s fees for eligible parties aiding in the placement, which will be disclosed at a later date. DelphX insiders can participate in the offering while adhering to the company's insider trading policies. Proceeds from the private placement are intended for general corporate purposes, furthering DelphX's mission in the structured products market.
DelphX Capital Markets, through its special purpose vehicle, Quantem LLC, aims to provide broker-dealers with innovative private placement securities that cover both fixed-income and cryptocurrency segments. Among its proprietary offerings are Collateralized Put Options and Collateralized Reference Notes, which offer secured protection against bond downgrades and cryptocurrency losses, respectively. These instruments are fully collateralized and managed by U.S. Bank, ensuring transparency and security.
The announcement includes forward-looking statements, highlighting the inherent risks and uncertainties associated with the financial sector and cryptocurrency volatility. Investors are advised to consider these factors carefully, as they may affect actual outcomes compared to projected results. For further details, DelphX encourages interested parties to visit their website.
MWN-AI** Analysis
DelphX Capital Markets Inc.’s recent announcement regarding a non-brokered private placement of up to 5,000,000 units at C$0.05 per unit presents both risks and opportunities for investors. The company aims to raise up to C$250,000, which it intends to use for general corporate purposes. This move signals DelphX's ongoing commitment to innovate in structured products, particularly within the growing segments of fixed-income and cryptocurrency solutions.
Investors considering participation in this offering should take into account the details of the warrants included. Each unit comprises a common share and a warrant to purchase another common share at C$0.08. This dual structure could either amplify returns if the stock appreciates or limit losses if the market conditions worsen. However, the warrant exercise price indicates that bullish sentiment would be needed for significant upside.
The capital raised will bolster DelphX’s operational capacity to enhance product development, which is vital in an industry that increasingly requires sophisticated risk management solutions, particularly given the volatility of cryptocurrency markets. The proprietary instruments, such as the Collateralized Put Options (CPOs) and Collateralized Reference Notes (CRNs), provide diversified investment opportunities for those looking to hedge against downturns or undesirable exposure in either corporate bonds or cryptocurrencies.
That said, it is essential to approach this offering with caution. Investors should consider the broader market conditions, including current demand for structured products and potential regulatory challenges. The private placement's reliance on insider participation also raises questions about market confidence and liquidity.
In summary, while the DelphX offering presents a unique entry point into innovative financial products, potential investors should weigh the inherent risks against the possible benefits, considering their investment strategy and risk tolerance carefully. Due diligence is advised before making any commitments.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Toronto, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to proceed with a non-brokered private placement ("the Offering") of up to 5,000,000 units (the "Units") at a subscription price of C$0.05 per Unit, for gross proceeds of up to C$250,000. Each Unit will consist of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Share at a price of C$0.08, for a period of two years from the date of issuance.
In connection with the Offering, DelphX may elect to pay finder's fees to eligible finders, and details of any finder’s fees paid will be announced at a later date.
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance. DelphX insiders may participate in the Offering, subject to compliance with DelphX's insider trading policy.
DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle, Quantem LLC, the Company enables broker-dealers to offer new private placement securities providing both fixed-income and cryptocurrency-based solutions. DelphX's proprietary securities include:
- Collateralized Put Options (CPOs), which provide secured protection against rating downgrades of corporate bonds and/or losses in cryptocurrency holdings; and
- Collateralized Reference Notes (CRNs), which enable investors to assume capped downgrade or cryptocurrency-loss exposure in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by U.S. Bank. These instruments are proprietary products created and owned by DelphX Capital Markets Inc.
For more information about DelphX, please visit www.delphx.com
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Forward-Looking Statements
This news release contains certain forward-looking statements, including statements regarding our business strategy and product development. Forward-looking statements involve risks and uncertainties, both known and unknown, that may cause actual results or events to be materially different from those expressed or implied by such forward-looking statements, including but not limited to, business, economic and capital market conditions, regulatory uncertainties, and the demand for our products. The forward-looking statements in this news release are based on factors and assumptions regarding, among other things, the state of the capital markets, the ability of DelphX to successfully manage the risks inherent in pursuing business opportunities in the financial services industry and the volatile crypto market, and the ability of DelphX to obtain qualified staff, equipment and services in a timely and cost-efficient manner to develop its business. Although we believe that the assumptions underlying these forward-looking statements are reasonable, they may prove to be incorrect. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements. Any forward-looking statement reflects information available to DelphX as of the date of this news release and, except as may be required by applicable laws, DelphX undertakes no intent or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or results or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ**
What are the primary competitive advantages of DelphX Capital Markets Inc. (DPXCF) in developing structured products compared to other companies in the financial services industry?
How does DelphX Capital Markets Inc. (DPXCF) plan to utilize the proceeds from its latest C$250,000 private placement, and what specific "general corporate purposes" will be prioritized?
Considering the volatile nature of the crypto market, how does DelphX Capital Markets Inc. (DPXCF) intend to mitigate risks associated with its proprietary products like CPOs and CRNs?
What factors does DelphX Capital Markets Inc. (DPXCF) believe will influence investor demand for its new structured products, especially in the current economic climate?
**MWN-AI FAQ is based on asking OpenAI questions about Delphx Capital Markets Inc. (OTC: DPXCF).
NASDAQ: DPXCF
DPXCF Trading
0.0% G/L:
$0.033 Last:
30,000 Volume:
$0.033 Open:
